Beam Therapeutics Ownership 2024 | Who Owns Beam Therapeutics Now?
Institutional Ownership
57.16%
Insider Ownership
1.44%
Retail Ownership
41.40%
Institutional Holders
154.00
Beam Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 10.61% | 1.87% | 8,182,174 | -1,211,715 | -12.90% | 270,339,043,000 | Mar 31, 2024 |
| VANGUARD GROUP INC | 9.82% | 0.01% | 7,578,768 | 413,892 | 5.78% | 250,402,494 | Mar 31, 2024 |
| BLACKROCK INC. | 8.69% | 0.01% | 6,705,626 | 43,583 | 0.65% | 221,553,881 | Mar 31, 2024 |
| FMR LLC | 6.34% | 0.01% | 4,894,453 | -1,285,869 | -20.81% | 161,712,727 | Mar 31, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 5.85% | 0.67% | 4,511,753 | 406,000 | 9.89% | 149,068,319 | Mar 31, 2024 |
| MORGAN STANLEY | 5.34% | 0.01% | 4,123,575 | -60,767 | -1.45% | 136,242,931 | Mar 31, 2024 |
| STATE STREET CORP | 4.84% | 0.01% | 3,731,192 | -885,166 | -19.17% | 123,278,584 | Mar 31, 2024 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 3.06% | 0.05% | 2,361,817 | 3,726 | 0.16% | 78,034,434 | Mar 31, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 3.06% | 0.77% | 2,361,817 | 3,726 | 0.16% | 77,892,725 | Mar 31, 2024 |
| MWG MANAGEMENT LTD. | 3.04% | 57.42% | 2,346,934 | - | - | 77,542,699 | Mar 31, 2024 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 2.75% | 9.32% | 2,119,598 | 2,119,598 | 100.00% | 70,031,518 | Mar 31, 2024 |
| REDMILE GROUP, LLC | 2.44% | 2.28% | 1,879,617 | 449,834 | 31.46% | 62,102,546 | Mar 31, 2024 |
| TEMASEK HOLDINGS (PRIVATE) LTD | 2.35% | 0.33% | 1,812,972 | -1,263,145 | -41.06% | 59,900,595 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.12% | 0.01% | 1,636,722 | 61,443 | 3.90% | 54,084,827 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.62% | 0.01% | 1,246,189 | 1,207,699 | 3137.70% | 41,175,000 | Mar 31, 2024 |
| BELLEVUE GROUP AG | 1.55% | 0.60% | 1,193,121 | 498,300 | 71.72% | 39,420,718 | Mar 31, 2024 |
| YIHENG CAPITAL MANAGEMENT, L.P. | 1.10% | 1.55% | 845,500 | - | - | 27,935,320 | Mar 31, 2024 |
| BAILLIE GIFFORD & CO | 0.98% | 0.02% | 752,394 | -11,729 | -1.53% | 24,859,099 | Mar 31, 2024 |
| CASDIN CAPITAL, LLC | 0.87% | 1.66% | 675,000 | 147,000 | 27.84% | 22,302,000 | Mar 31, 2024 |
| NORTHERN TRUST CORP | 0.85% | 0.00% | 659,180 | -9,362 | -1.40% | 21,779,307 | Mar 31, 2024 |
Beam Therapeutics's largest institutional shareholder is ARK INVESTMENT MANAGEMENT LLC, holding 10.61% of the company's total share outstanding, currently valued at $270.34B. The top 10 institutional shareholders own together 60.66% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MWG MANAGEMENT LTD. | 3.04% | 57.42% | 2,346,934 | - | - | 77,542,699 | Mar 31, 2024 |
| DARWIN GLOBAL MANAGEMENT, LTD. | 2.75% | 9.32% | 2,119,598 | 2,119,598 | 100.00% | 70,031,518 | Mar 31, 2024 |
| REDMILE GROUP, LLC | 2.44% | 2.28% | 1,879,617 | 449,834 | 31.46% | 62,102,546 | Mar 31, 2024 |
| ARK INVESTMENT MANAGEMENT LLC | 10.61% | 1.87% | 8,182,174 | -1,211,715 | -12.90% | 270,339,043,000 | Mar 31, 2024 |
| CASDIN CAPITAL, LLC | 0.87% | 1.66% | 675,000 | 147,000 | 27.84% | 22,302,000 | Mar 31, 2024 |
| YIHENG CAPITAL MANAGEMENT, L.P. | 1.10% | 1.55% | 845,500 | - | - | 27,935,320 | Mar 31, 2024 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 3.06% | 0.77% | 2,361,817 | 3,726 | 0.16% | 77,892,725 | Mar 31, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 5.85% | 0.67% | 4,511,753 | 406,000 | 9.89% | 149,068,319 | Mar 31, 2024 |
| BELLEVUE GROUP AG | 1.55% | 0.60% | 1,193,121 | 498,300 | 71.72% | 39,420,718 | Mar 31, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.39% | 0.43% | 300,000 | 300,000 | 100.00% | 9,912,000 | Mar 31, 2024 |
| ALPHABET INC. | 0.42% | 0.42% | 321,604 | - | - | 10,625,796 | Mar 31, 2024 |
| SCIENTECH RESEARCH LLC | 0.03% | 0.34% | 19,407 | 10,875 | 127.46% | 641,207 | Mar 31, 2024 |
| TEMASEK HOLDINGS (PRIVATE) LTD | 2.35% | 0.33% | 1,812,972 | -1,263,145 | -41.06% | 59,900,595 | Mar 31, 2024 |
| GREEN ALPHA ADVISORS, LLC | 0.02% | 0.33% | 13,636 | -273 | -1.96% | 450,533 | Mar 31, 2024 |
| BRANDYWINE MANAGERS, LLC | 0.01% | 0.26% | 8,067 | - | - | 266,534 | Mar 31, 2024 |
| PDT PARTNERS, LLC | 0.07% | 0.17% | 55,649 | 55,649 | 100.00% | 1,838,643 | Mar 31, 2024 |
| VESTMARK ADVISORY SOLUTIONS, INC. | 0.15% | 0.16% | 114,786 | 16,571 | 16.87% | 3,792,529 | Mar 31, 2024 |
| CLARIUS GROUP, LLC | 0.08% | 0.14% | 60,615 | - | - | 2,002,720 | Mar 31, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.02% | 0.13% | 15,496 | 15,496 | 100.00% | 511,988 | Mar 31, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 0.19% | 0.12% | 147,510 | 36,080 | 32.38% | 4,873,730 | Mar 31, 2024 |
The largest Beam Therapeutics shareholder by % of total assets is MWG MANAGEMENT LTD.. The company owns 2.35M shares of Beam Therapeutics (BEAM), representing 57.42% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DARWIN GLOBAL MANAGEMENT, LTD. | 2.75% | 9.32% | 2,119,598 | 2,119,598 | 100.00% | 70,031,518 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.62% | 0.01% | 1,246,189 | 1,207,699 | 3137.70% | 41,175,000 | Mar 31, 2024 |
| BELLEVUE GROUP AG | 1.55% | 0.60% | 1,193,121 | 498,300 | 71.72% | 39,420,718 | Mar 31, 2024 |
| REDMILE GROUP, LLC | 2.44% | 2.28% | 1,879,617 | 449,834 | 31.46% | 62,102,546 | Mar 31, 2024 |
| VANGUARD GROUP INC | 9.82% | 0.01% | 7,578,768 | 413,892 | 5.78% | 250,402,494 | Mar 31, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 5.85% | 0.67% | 4,511,753 | 406,000 | 9.89% | 149,068,319 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.47% | 0.03% | 358,798 | 358,798 | 100.00% | 11,854,686 | Mar 31, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.39% | 0.43% | 300,000 | 300,000 | 100.00% | 9,912,000 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.28% | 0.00% | 213,500 | 213,500 | 100.00% | 7,054,040 | Mar 31, 2024 |
| TD ASSET MANAGEMENT INC | 0.21% | 0.01% | 162,692 | 162,692 | 100.00% | 5,375,344 | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | 0.19% | 0.01% | 148,200 | 148,200 | 100.00% | 4,896,528 | Mar 31, 2024 |
| CASDIN CAPITAL, LLC | 0.87% | 1.66% | 675,000 | 147,000 | 27.84% | 22,302,000 | Mar 31, 2024 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 0.19% | 0.11% | 144,554 | 144,554 | 100.00% | 4,776,064 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.42% | 0.00% | 321,052 | 126,724 | 65.21% | 10,607,557,000 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.13% | 0.00% | 102,700 | 102,700 | 100.00% | 3,393,208 | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.13% | 0.01% | 98,055 | 98,055 | 100.00% | 3,239,737 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.13% | 0.01% | 97,737 | 97,737 | 100.00% | 3,229,230 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.11% | 0.00% | 81,629 | 81,629 | 100.00% | 2,697,022 | Mar 31, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.31% | 0.03% | 236,387 | 78,139 | 49.38% | 7,810,226 | Mar 31, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.83% | 0.01% | 641,861 | 75,003 | 13.23% | 21,207,088 | Mar 31, 2024 |
As of Mar 31 2024, Beam Therapeutics's largest institutional buyer is DARWIN GLOBAL MANAGEMENT, LTD.. The company purchased 2.12M stocks of BEAM, valued at $70.03M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 6.34% | 0.01% | 4,894,453 | -1,285,869 | -20.81% | 161,712,727 | Mar 31, 2024 |
| TEMASEK HOLDINGS (PRIVATE) LTD | 2.35% | 0.33% | 1,812,972 | -1,263,145 | -41.06% | 59,900,595 | Mar 31, 2024 |
| ARK INVESTMENT MANAGEMENT LLC | 10.61% | 1.87% | 8,182,174 | -1,211,715 | -12.90% | 270,339,043,000 | Mar 31, 2024 |
| STATE STREET CORP | 4.84% | 0.01% | 3,731,192 | -885,166 | -19.17% | 123,278,584 | Mar 31, 2024 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -350,000 | -100.00% | - | Mar 31, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | - | - | - | -261,360 | -100.00% | - | Mar 31, 2024 |
| CANDRIAM S.C.A. | - | - | - | -212,665 | -100.00% | - | Mar 31, 2024 |
| JANE STREET GROUP, LLC | 0.22% | 0.00% | 171,817 | -176,231 | -50.63% | 5,676,834 | Mar 31, 2024 |
| BARCLAYS PLC | 0.11% | 0.00% | 86,676 | -161,708 | -65.10% | 2,864,000 | Mar 31, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.38% | 0.00% | 289,888 | -148,517 | -33.88% | 9,577,876 | Mar 31, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.32% | 0.03% | 244,354 | -95,363 | -28.07% | 8,073,456 | Mar 31, 2024 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | - | - | - | -68,050 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | 5.34% | 0.01% | 4,123,575 | -60,767 | -1.45% | 136,242,931 | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 0.60% | 0.00% | 465,486 | -57,947 | -11.07% | 15,379,658 | Mar 31, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.39% | 0.01% | 302,020 | -50,789 | -14.40% | 9,978,741 | Mar 31, 2024 |
| AMERIPRISE FINANCIAL INC | 0.30% | 0.00% | 228,905 | -37,090 | -13.94% | 7,563,013 | Mar 31, 2024 |
| HARBOR CAPITAL ADVISORS, INC. | - | - | - | -34,918 | -100.00% | - | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.00% | 0.00% | 3,200 | -34,100 | -91.42% | 105,728 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.00% | 0.00% | 1,800 | -28,600 | -94.08% | 59,472 | Mar 31, 2024 |
| WALLEYE TRADING LLC | - | - | - | -27,400 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Beam Therapeutics's biggest institutional seller is FMR LLC. The company sold -1.29M shares of BEAM, valued at $161.71M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DARWIN GLOBAL MANAGEMENT, LTD. | 2.75% | 9.32% | 2,119,598 | 2,119,598 | 100.00% | 70,031,518 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.47% | 0.03% | 358,798 | 358,798 | 100.00% | 11,854,686 | Mar 31, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.39% | 0.43% | 300,000 | 300,000 | 100.00% | 9,912,000 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.28% | 0.00% | 213,500 | 213,500 | 100.00% | 7,054,040 | Mar 31, 2024 |
| TD ASSET MANAGEMENT INC | 0.21% | 0.01% | 162,692 | 162,692 | 100.00% | 5,375,344 | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | 0.19% | 0.01% | 148,200 | 148,200 | 100.00% | 4,896,528 | Mar 31, 2024 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 0.19% | 0.11% | 144,554 | 144,554 | 100.00% | 4,776,064 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.13% | 0.00% | 102,700 | 102,700 | 100.00% | 3,393,208 | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.13% | 0.01% | 98,055 | 98,055 | 100.00% | 3,239,737 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.13% | 0.01% | 97,737 | 97,737 | 100.00% | 3,229,230 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.11% | 0.00% | 81,629 | 81,629 | 100.00% | 2,697,022 | Mar 31, 2024 |
| PDT PARTNERS, LLC | 0.07% | 0.17% | 55,649 | 55,649 | 100.00% | 1,838,643 | Mar 31, 2024 |
| POINT72 HONG KONG LTD | 0.06% | 0.08% | 48,325 | 48,325 | 100.00% | 1,596,658 | Mar 31, 2024 |
| TUDOR INVESTMENT CORP ET AL | 0.06% | 0.01% | 47,845 | 47,845 | 100.00% | 1,580,799 | Mar 31, 2024 |
| BARCLAYS PLC | 0.06% | 0.00% | 47,000 | 47,000 | 100.00% | 1,553,000 | Mar 31, 2024 |
| CAPTION MANAGEMENT, LLC | 0.05% | 0.02% | 35,000 | 35,000 | 100.00% | 1,156,400 | Mar 31, 2024 |
| TWINBEECH CAPITAL LP | 0.04% | 0.02% | 34,641 | 34,641 | 100.00% | 1,144,539 | Mar 31, 2024 |
| BAMCO INC /NY/ | 0.04% | 0.00% | 30,000 | 30,000 | 100.00% | 991,200 | Mar 31, 2024 |
| LMR PARTNERS LLP | 0.03% | 0.01% | 20,400 | 20,400 | 100.00% | 674,016 | Mar 31, 2024 |
| 0.02% | 0.02% | 18,622 | 18,622 | 100.00% | 615,271 | Mar 31, 2024 | |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.02% | 0.13% | 15,496 | 15,496 | 100.00% | 511,988 | Mar 31, 2024 |
| PEARL RIVER CAPITAL, LLC | 0.02% | 0.08% | 15,429 | 15,429 | 100.00% | 509,774 | Mar 31, 2024 |
| GOTHAM ASSET MANAGEMENT, LLC | 0.02% | 0.01% | 14,932 | 14,932 | 100.00% | 493,353 | Mar 31, 2024 |
| CAPITAL FUND MANAGEMENT S.A. | 0.02% | 0.00% | 14,700 | 14,700 | 100.00% | 485,688 | Mar 31, 2024 |
| CREATIVE PLANNING | 0.02% | 0.00% | 12,061 | 12,061 | 100.00% | 398,495 | Mar 31, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.02% | 0.00% | 11,864 | 11,864 | 100.00% | 392,000 | Mar 31, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | 0.01% | 0.00% | 10,734 | 10,734 | 100.00% | 354,651 | Mar 31, 2024 |
| PEAK6 INVESTMENTS LLC | 0.01% | 0.00% | 10,700 | 10,700 | 100.00% | 353,528 | Mar 31, 2024 |
| FISHMAN JAY A LTD/MI | 0.01% | 0.04% | 10,000 | 10,000 | 100.00% | 330,400 | Mar 31, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | 0.01% | 0.03% | 8,803 | 8,803 | 100.00% | 290,851 | Mar 31, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | 0.01% | 0.01% | 7,900 | 7,900 | 100.00% | 261,016 | Mar 31, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.01% | 0.00% | 7,894 | 7,894 | 100.00% | 260,818 | Mar 31, 2024 |
| STIFEL FINANCIAL CORP | 0.01% | 0.00% | 7,626 | 7,626 | 100.00% | 251,966 | Mar 31, 2024 |
| STEEL PEAK WEALTH MANAGEMENT LLC | 0.01% | 0.01% | 7,505 | 7,505 | 100.00% | 247,966 | Mar 31, 2024 |
| DLK INVESTMENT MANAGEMENT, LLC | 0.01% | 0.10% | 7,225 | 7,225 | 100.00% | 238,714 | Mar 31, 2024 |
| THRIVE WEALTH MANAGEMENT, LLC | 0.01% | 0.05% | 6,925 | 6,925 | 100.00% | 228,802 | Mar 31, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.01% | 0.00% | 6,524 | 6,524 | 100.00% | 215,553 | Mar 31, 2024 |
| MCGUIRE INVESTMENT GROUP, LLC | 0.01% | 0.03% | 6,250 | 6,250 | 100.00% | 206,500 | Mar 31, 2024 |
| REYNDERS MCVEIGH CAPITAL MANAGEMENT, LLC | 0.01% | 0.01% | 6,055 | 6,055 | 100.00% | 201,000 | Mar 31, 2024 |
| QUEST PARTNERS LLC | 0.01% | 0.03% | 4,953 | 4,953 | 100.00% | 163,647 | Mar 31, 2024 |
| QUANTBOT TECHNOLOGIES LP | 0.00% | 0.01% | 2,800 | 2,800 | 100.00% | 92,512 | Mar 31, 2024 |
| STRS OHIO | 0.00% | 0.00% | 1,500 | 1,500 | 100.00% | 49,000 | Mar 31, 2024 |
| SANDY SPRING BANK | 0.00% | 0.00% | 1,200 | 1,200 | 100.00% | 39,648,000 | Mar 31, 2024 |
| PACER ADVISORS, INC. | 0.00% | 0.00% | 1,134 | 1,134 | 100.00% | 37,467 | Mar 31, 2024 |
| QUARRY LP | 0.00% | 0.01% | 800 | 800 | 100.00% | 26,432 | Mar 31, 2024 |
| RIVERVIEW TRUST CO | 0.00% | 0.02% | 796 | 796 | 100.00% | 26,300 | Mar 31, 2024 |
| TRUST CO OF VERMONT | 0.00% | 0.00% | 200 | 200 | 100.00% | 6,608 | Mar 31, 2024 |
| RFP FINANCIAL GROUP LLC | 0.00% | 0.00% | 170 | 170 | 100.00% | 5,617 | Mar 31, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.00% | - | 150 | 150 | 100.00% | 4,899,000 | Mar 31, 2024 |
| RALEIGH CAPITAL MANAGEMENT INC. | 0.00% | 0.00% | 100 | 100 | 100.00% | 3,304,000 | Mar 31, 2024 |
| MACROVIEW INVESTMENT MANAGEMENT LLC | 0.00% | 0.00% | 80 | 80 | 100.00% | 2,644 | Mar 31, 2024 |
| PISCATAQUA SAVINGS BANK | 0.00% | 0.00% | 50 | 50 | 100.00% | 1,652,000 | Mar 31, 2024 |
| - | 0.00% | 18 | 18 | 100.00% | 595 | Mar 31, 2024 | |
| SMARTLEAF ASSET MANAGEMENT LLC | - | 0.00% | 15 | 15 | 100.00% | 441,000 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | 14 | 14 | 100.00% | 462 | Mar 31, 2024 |
Beam Therapeutics's largest new institutional shareholder by number of shares is DARWIN GLOBAL MANAGEMENT, LTD., purchased 2.12M shares, valued at $70.03M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -350,000 | -100.00% | - | Mar 31, 2024 |
| EVENTIDE ASSET MANAGEMENT, LLC | - | - | - | -261,360 | -100.00% | - | Mar 31, 2024 |
| CANDRIAM S.C.A. | - | - | - | -212,665 | -100.00% | - | Mar 31, 2024 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | - | - | - | -68,050 | -100.00% | - | Mar 31, 2024 |
| HARBOR CAPITAL ADVISORS, INC. | - | - | - | -34,918 | -100.00% | - | Mar 31, 2024 |
| WALLEYE TRADING LLC | - | - | - | -27,400 | -100.00% | - | Mar 31, 2024 |
| CAXTON ASSOCIATES LP | - | - | - | -18,703 | -100.00% | - | Mar 31, 2024 |
| CORTON CAPITAL INC. | - | - | - | -11,903 | -100.00% | - | Mar 31, 2024 |
| CIBC WORLD MARKET INC. | - | - | - | -10,181 | -100.00% | - | Mar 31, 2024 |
| TORNO CAPITAL, LLC | - | - | - | -10,000 | -100.00% | - | Mar 31, 2024 |
| CAPITAL IMPACT ADVISORS, LLC | - | - | - | -8,229 | -100.00% | - | Mar 31, 2024 |
| PARALLAX VOLATILITY ADVISERS, L.P. | - | - | - | -7,400 | -100.00% | - | Mar 31, 2024 |
| VIRTUS INVESTMENT ADVISERS, INC. | - | - | - | -3,049 | -100.00% | - | Mar 31, 2024 |
| ADVISORY SERVICES NETWORK, LLC | - | - | - | -476 | -100.00% | - | Mar 31, 2024 |
| VIRTUS FUND ADVISERS, LLC | - | - | - | -467 | -100.00% | - | Mar 31, 2024 |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | - | - | - | -250 | -100.00% | - | Mar 31, 2024 |
| ITAU UNIBANCO HOLDING S.A. | - | - | - | -236 | -100.00% | - | Mar 31, 2024 |
| GLASSMAN WEALTH SERVICES | - | - | - | -120 | -100.00% | - | Mar 31, 2024 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | - | - | - | -50 | -100.00% | - | Mar 31, 2024 |
| CUTLER GROUP LLC / CA | - | - | - | -50 | -100.00% | - | Mar 31, 2024 |
| CREWE ADVISORS LLC | - | - | - | -6 | -100.00% | - | Mar 31, 2024 |
Beam Therapeutics's largest sold out institutional shareholder by shares sold is TANG CAPITAL MANAGEMENT LLC, sold -0.35M shares, valued at -, as of undefined.
Beam Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Ark ETF Trust | 1.02% | 8,205,123 | -364,328 | -4.25% | Jan 31, 2024 |
| Manager Directed Portfolios | 0.70% | 114,002 | - | - | Jan 31, 2024 |
| Kelly Strategic ETF Trust | 0.45% | 12,306 | - | - | Feb 29, 2024 |
| Ark Venture Fund | 0.19% | 17,951 | 5,447 | 43.56% | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.10% | 51,311 | - | - | Dec 31, 2023 |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | 0.08% | 10,281 | - | - | Dec 31, 2023 |
| FIDELITY MT VERNON STREET TRUST | 0.04% | 1,272,351 | -53,984 | -4.07% | Feb 29, 2024 |
| Federated Hermes MDT Series | 0.04% | 94,845 | - | - | Jan 31, 2024 |
| RENAISSANCE CAPITAL GREENWICH FUNDS | 0.04% | 23,223 | - | - | Dec 31, 2023 |
| FIDELITY ADVISOR SERIES VII | 0.03% | 280,000 | - | - | Jan 31, 2024 |
| Humankind Benefit Corp | 0.03% | 718 | -115 | -13.81% | Dec 31, 2023 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.03% | 15,710 | - | - | Dec 31, 2023 |
| EntrepreneurShares Series Trust | 0.03% | 8,229 | -4,371 | -34.69% | Dec 31, 2023 |
| ALGER FUNDS | 0.03% | 29,561 | - | - | Jan 31, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.03% | 88,706 | - | - | Mar 31, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.03% | 8,809 | - | - | Dec 31, 2023 |
| TEKLA LIFE SCIENCES INVESTORS | 0.03% | 15,817 | - | - | Dec 31, 2023 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 11,044 | 688 | 6.64% | Dec 31, 2023 |
| AMG FUNDS III | 0.02% | 3,820 | - | - | Feb 29, 2024 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.02% | 13,483 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.02% | 56,000 | - | - | Dec 31, 2023 |
| Listed Funds Trust | 0.02% | 9,597 | - | - | Feb 29, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 127,243 | 8,966 | 7.58% | Dec 31, 2023 |
| Voya EQUITY TRUST | 0.02% | 27,819 | - | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,158,150 | - | - | Feb 29, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.02% | 3,131 | - | - | Dec 29, 2023 |
| T. Rowe Price New Horizons Fund, Inc. | 0.02% | 236,893 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.02% | 7,351,864 | 1,371,573 | 22.93% | Dec 31, 2023 |
| ACAP Strategic Fund | 0.02% | 213,102 | - | - | Dec 31, 2023 |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0.01% | 91,200 | - | - | Dec 31, 2023 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.01% | 53,200 | - | - | Jan 31, 2024 |
| BlackRock Health Sciences Trust II | 0.01% | 35,888 | - | - | Dec 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 32,717 | 527 | 1.64% | Feb 29, 2024 |
| Jacob Funds Inc. | 0.01% | 2,188 | -2,527 | -53.59% | Feb 29, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 82,900 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,758 | - | - | Dec 31, 2023 |
| Harbor ETF Trust | 0.01% | 35,335 | 4,255 | 13.69% | Jan 31, 2024 |
| DEUTSCHE DWS SECURITIES TRUST | 0.01% | 3,600 | - | - | Feb 29, 2024 |
| SMALLCAP WORLD FUND INC | 0.01% | 442,725 | - | - | Dec 31, 2023 |
| RYDEX SERIES FUNDS | 0.01% | 25,183 | -5,594 | -18.18% | Dec 31, 2023 |
| LORD ABBETT SECURITIES TRUST | 0.01% | 26,003 | - | - | Jan 31, 2024 |
| Nushares ETF Trust | 0.01% | 38,992 | - | - | Jan 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.01% | 100,000 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 37,176 | 17,525 | 89.18% | Jan 31, 2024 |
| FORUM FUNDS II | 0.00% | 3,320 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 63,170 | -5,292 | -7.73% | Dec 31, 2023 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.00% | 8,000 | - | - | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 691,843 | 49,675 | 7.74% | Feb 29, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.00% | 26,576 | - | - | Dec 29, 2023 |
| Calvert Variable Products, Inc. | 0.00% | 7,503 | 713 | 10.50% | Dec 31, 2023 |
| VANGUARD EXPLORER FUND | 0.00% | 37,652 | - | - | Jan 31, 2024 |
| PROFESSIONALLY MANAGED PORTFOLIOS | 0.00% | 15,356 | - | - | Feb 29, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.00% | 26,412 | - | - | Feb 29, 2024 |
| IndexIQ ETF Trust | 0.00% | 5,289 | - | - | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 2,712 | -665 | -19.69% | Dec 31, 2023 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 23,830 | - | - | Dec 31, 2023 |
| John Hancock Exchange-Traded Fund Trust | 0.00% | 13,683 | - | - | Jan 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 326,171 | 59,073 | 22.12% | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 370,380 | 27,103 | 7.90% | Feb 29, 2024 |
| ETFis Series Trust I | 0.00% | 2,755 | 2,755 | - | Jan 31, 2024 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 1,292 | - | - | Sep 30, 2023 |
| Destra Investment Trust | 0.00% | 2,714 | - | - | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 47,486 | - | - | Dec 31, 2023 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 3,435 | - | - | Mar 31, 2024 |
| BARON SELECT FUNDS | 0.00% | 15,717 | - | - | Dec 31, 2023 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.00% | 51,770 | - | - | Dec 31, 2023 |
| BLACKROCK LARGE CAP SERIES FUNDS, INC. | 0.00% | 47,552 | - | - | Feb 29, 2024 |
| HUSSMAN INVESTMENT TRUST | 0.00% | 3,600 | - | - | Dec 31, 2023 |
| VANGUARD WORLD FUND | 0.00% | 245,111 | 11,619 | 4.98% | Feb 29, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 129,469 | -82,598 | -38.95% | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 6,310 | - | - | Aug 31, 2023 |
| MORGAN STANLEY INSTITUTIONAL FUND INC | 0.00% | 47,860 | -1,257 | -2.56% | Dec 31, 2023 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 28,572 | 941 | 3.41% | Dec 31, 2023 |
| AMERICAN PENSION INVESTORS TRUST | 0.00% | 5,005 | - | - | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 2,959 | - | - | Dec 31, 2023 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 3,442 | -186 | -5.13% | Dec 31, 2023 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 13,025 | - | - | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 10,183 | - | - | Feb 29, 2024 |
| DEUTSCHE DWS VARIABLE SERIES II | 0.00% | 1,593 | - | - | Dec 31, 2023 |
| Principal Exchange-Traded Funds | 0.00% | 8,533 | -702 | -7.60% | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 13,653 | - | - | Dec 31, 2023 |
| Dimensional ETF Trust | 0.00% | 288,032 | 79,283 | 37.98% | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 71,690 | 30,332 | 73.34% | Feb 29, 2024 |
| SunAmerica Specialty Series | 0.00% | 291 | - | - | Apr 30, 2021 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 7,021 | -1,502 | -17.62% | Dec 31, 2023 |
| JPMORGAN INSURANCE TRUST | 0.00% | 6,156 | -244 | -3.81% | Mar 31, 2023 |
| FIDELITY ADVISOR SERIES I | 0.00% | 83,761 | -105 | -0.13% | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,068 | - | - | Dec 31, 2023 |
| Meeder Funds | 0.00% | 1,858 | - | - | Mar 31, 2024 |
| Spinnaker ETF Series | 0.00% | 245 | - | - | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 2,900 | - | - | Dec 31, 2023 |
| BlackRock ETF Trust | 0.00% | 268 | 181 | 208.05% | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 26,200 | 2,700 | 11.49% | Dec 31, 2023 |
| RUSSELL INVESTMENT CO | 0.00% | 86,094 | -5,734 | -6.24% | Jan 31, 2024 |
| BNY MELLON FUNDS TRUST | 0.00% | 16,455 | 16,455 | - | Feb 29, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 16,791 | 18 | 0.11% | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 218,691 | 4,038 | 1.88% | Dec 31, 2023 |
| HC CAPITAL TRUST | 0.00% | 5,353 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 332,149 | 50,598 | 17.97% | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 13,316 | 4,087 | 44.28% | Dec 31, 2023 |
Beam Therapeutics's largest mutual fund holder by % of total assets is "Ark ETF Trust", owning 8.21M shares, compromising 1.02% of its total assets.
Beam Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 154 | -18.95% |
| 31 Dec, 23 | 190 | -2.56% |
| 30 Sep, 23 | 195 | - |
| 30 Jun, 23 | 195 | -6.70% |
| 31 Mar, 23 | 209 | -4.13% |
| 31 Dec, 22 | 218 | -2.68% |
| 30 Sep, 22 | 224 | 13.71% |
| 30 Jun, 22 | 197 | -17.23% |
| 31 Mar, 22 | 238 | 2.15% |
| 31 Dec, 21 | 233 | 0.87% |
| 30 Sep, 21 | 231 | -3.75% |
| 30 Jun, 21 | 240 | 9.09% |
| 31 Mar, 21 | 220 | 37.50% |
| 31 Dec, 20 | 160 | 90.48% |
| 30 Sep, 20 | 84 | 18.31% |
| 30 Jun, 20 | 71 | 18.33% |
| 31 Mar, 20 | 60 | - |
As of 31 Mar 24, 154 institutions are holding Beam Therapeutics's shares, representing a decrease of -18.95% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 44,098,162 | -35.76% |
| 31 Dec, 23 | 68,645,761 | 2.57% |
| 30 Sep, 23 | 66,926,474 | 4.85% |
| 30 Jun, 23 | 63,832,708 | 6.81% |
| 31 Mar, 23 | 59,761,032 | 7.01% |
| 31 Dec, 22 | 55,846,410 | 2.56% |
| 30 Sep, 22 | 54,452,416 | -0.44% |
| 30 Jun, 22 | 54,690,443 | 11.32% |
| 31 Mar, 22 | 49,128,540 | 8.12% |
| 31 Dec, 21 | 45,437,200 | 0.77% |
| 30 Sep, 21 | 45,090,144 | -0.80% |
| 30 Jun, 21 | 45,452,350 | 6.42% |
| 31 Mar, 21 | 42,709,535 | 15.94% |
| 31 Dec, 20 | 36,837,156 | 24.77% |
| 30 Sep, 20 | 29,524,623 | 6.56% |
| 30 Jun, 20 | 27,707,888 | 3.05% |
| 31 Mar, 20 | 26,888,544 | - |
Beam Therapeutics (BEAM) has 44.10M shares outstanding as of 31 Mar 24, down -35.76% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 57.16% | 0.76% |
| 31 Dec, 23 | 86.87% | 1.13% |
| 30 Sep, 23 | 87.67% | 1.12% |
| 30 Jun, 23 | 88.32% | 1.29% |
| 31 Mar, 23 | 82.69% | 1.30% |
| 31 Dec, 22 | 79.76% | 1.33% |
| 30 Sep, 22 | 77.41% | 1.28% |
| 30 Jun, 22 | 77.90% | 1.52% |
| 31 Mar, 22 | 71.51% | 1.60% |
| 31 Dec, 21 | 66.83% | 1.45% |
| 30 Sep, 21 | 67.93% | 1.27% |
| 30 Jun, 21 | 73.06% | 1.45% |
| 31 Mar, 21 | 70.93% | 1.90% |
| 31 Dec, 20 | 61.18% | 1.76% |
| 30 Sep, 20 | 58.95% | 1.88% |
| 30 Jun, 20 | 56.05% | 0.73% |
| 31 Mar, 20 | 87.51% | - |
As of 31 Mar 24, Beam Therapeutics is held by 57.16% institutional shareholders, representing a 0.76% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 89 | -12.75% |
| 31 Dec, 23 | 102 | -8.93% |
| 30 Sep, 23 | 112 | 14.29% |
| 30 Jun, 23 | 98 | -5.77% |
| 31 Mar, 23 | 104 | -9.57% |
| 31 Dec, 22 | 115 | -1.71% |
| 30 Sep, 22 | 117 | -0.85% |
| 30 Jun, 22 | 118 | -15.71% |
| 31 Mar, 22 | 140 | 18.64% |
| 31 Dec, 21 | 118 | -11.28% |
| 30 Sep, 21 | 133 | -6.34% |
| 30 Jun, 21 | 142 | 7.58% |
| 31 Mar, 21 | 132 | 9.09% |
| 31 Dec, 20 | 121 | 116.07% |
| 30 Sep, 20 | 56 | 27.27% |
| 30 Jun, 20 | 44 | -26.67% |
| 31 Mar, 20 | 60 | - |
89 institutional shareholders have increased their position in BEAM stock as of 31 Mar 24 compared to 102 in the previous quarter (a -12.75% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 31 | -41.51% |
| 31 Dec, 23 | 53 | 29.27% |
| 30 Sep, 23 | 41 | -2.38% |
| 30 Jun, 23 | 42 | -26.32% |
| 31 Mar, 23 | 57 | - |
| 31 Dec, 22 | 57 | -10.94% |
| 30 Sep, 22 | 64 | 68.42% |
| 30 Jun, 22 | 38 | -13.64% |
| 31 Mar, 22 | 44 | -34.33% |
| 31 Dec, 21 | 67 | 52.27% |
| 30 Sep, 21 | 44 | -6.38% |
| 30 Jun, 21 | 47 | 14.63% |
| 31 Mar, 21 | 41 | 355.56% |
| 31 Dec, 20 | 9 | -10.00% |
| 30 Sep, 20 | 10 | - |
| 30 Jun, 20 | 10 | - |
| 31 Mar, 20 | - | - |
31 institutional shareholders have reduced their position in BEAM stock as of 31 Mar 24 compared to 53 in the previous quarter (a -41.51% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 154 | -18.95% | 44,098,162 | -35.76% | 57.16% | 0.76% | 89 | -12.75% | 31 | -41.51% |
| 31 Dec, 23 | 190 | -2.56% | 68,645,761 | 2.57% | 86.87% | 1.13% | 102 | -8.93% | 53 | 29.27% |
| 30 Sep, 23 | 195 | - | 66,926,474 | 4.85% | 87.67% | 1.12% | 112 | 14.29% | 41 | -2.38% |
| 30 Jun, 23 | 195 | -6.70% | 63,832,708 | 6.81% | 88.32% | 1.29% | 98 | -5.77% | 42 | -26.32% |
| 31 Mar, 23 | 209 | -4.13% | 59,761,032 | 7.01% | 82.69% | 1.30% | 104 | -9.57% | 57 | - |
| 31 Dec, 22 | 218 | -2.68% | 55,846,410 | 2.56% | 79.76% | 1.33% | 115 | -1.71% | 57 | -10.94% |
| 30 Sep, 22 | 224 | 13.71% | 54,452,416 | -0.44% | 77.41% | 1.28% | 117 | -0.85% | 64 | 68.42% |
| 30 Jun, 22 | 197 | -17.23% | 54,690,443 | 11.32% | 77.90% | 1.52% | 118 | -15.71% | 38 | -13.64% |
| 31 Mar, 22 | 238 | 2.15% | 49,128,540 | 8.12% | 71.51% | 1.60% | 140 | 18.64% | 44 | -34.33% |
| 31 Dec, 21 | 233 | 0.87% | 45,437,200 | 0.77% | 66.83% | 1.45% | 118 | -11.28% | 67 | 52.27% |
| 30 Sep, 21 | 231 | -3.75% | 45,090,144 | -0.80% | 67.93% | 1.27% | 133 | -6.34% | 44 | -6.38% |
| 30 Jun, 21 | 240 | 9.09% | 45,452,350 | 6.42% | 73.06% | 1.45% | 142 | 7.58% | 47 | 14.63% |
| 31 Mar, 21 | 220 | 37.50% | 42,709,535 | 15.94% | 70.93% | 1.90% | 132 | 9.09% | 41 | 355.56% |
| 31 Dec, 20 | 160 | 90.48% | 36,837,156 | 24.77% | 61.18% | 1.76% | 121 | 116.07% | 9 | -10.00% |
| 30 Sep, 20 | 84 | 18.31% | 29,524,623 | 6.56% | 58.95% | 1.88% | 56 | 27.27% | 10 | - |
| 30 Jun, 20 | 71 | 18.33% | 27,707,888 | 3.05% | 56.05% | 0.73% | 44 | -26.67% | 10 | - |
| 31 Mar, 20 | 60 | - | 26,888,544 | - | 87.51% | - | 60 | - | - | - |
Beam Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Beam Therapeutics's stock was made by Simon Amy on Apr 03 2024, selling 7,157 shares at $32.13 per share (valued at $229.95K).
Beam Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2033 | 1 | - | - |
| Q2 2024 | 6 | 6 | 100.00% |
| Q1 2024 | 10 | 7 | 142.86% |
| Q4 2023 | 4 | 8 | 50.00% |
| Q3 2023 | 3 | 6 | 50.00% |
| Q2 2023 | 5 | 11 | 45.45% |
| Q1 2023 | 21 | 29 | 72.41% |
| Q4 2022 | 3 | 15 | 20.00% |
| Q3 2022 | 16 | 8 | 200.00% |
| Q2 2022 | 4 | 9 | 44.44% |
| Q1 2022 | 7 | 16 | 43.75% |
| Q4 2021 | 6 | 20 | 30.00% |
| Q3 2021 | 19 | 47 | 40.43% |
| Q2 2021 | 31 | 48 | 64.58% |
| Q1 2021 | 25 | 27 | 92.59% |
| Q4 2020 | 2 | 21 | 9.52% |
| Q3 2020 | 3 | 2 | 150.00% |
| Q2 2020 | 1 | 1 | 100.00% |
| Q1 2020 | 19 | 29 | 65.52% |
| Q1 2014 | - | 2 | - |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Beam Therapeutics's insiders, as of Q2 2033.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2033 | - | - | - |
| Q2 2024 | - | 6 | - |
| Q1 2024 | - | 7 | - |
| Q4 2023 | - | 4 | - |
| Q3 2023 | - | 3 | - |
| Q2 2023 | - | 11 | - |
| Q1 2023 | - | 7 | - |
| Q4 2022 | - | 11 | - |
| Q3 2022 | - | 4 | - |
| Q2 2022 | - | 5 | - |
| Q1 2022 | - | 15 | - |
| Q4 2021 | - | 14 | - |
| Q3 2021 | - | 31 | - |
| Q2 2021 | - | 27 | - |
| Q1 2021 | - | 7 | - |
| Q4 2020 | - | 19 | - |
| Q3 2020 | - | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q1 2014 | - | 2 | - |
As of Q2 2033, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Beam Therapeutics's stocks.
Beam Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| VERV | Verve Therapeutics, Inc. |
| FATE | Fate Therapeutics, Inc. |
| DNA | Ginkgo Bioworks Holdings, Inc. |
| PRME | Prime Medicine, Inc. |
| CRSP | CRISPR Therapeutics AG |
| NTLA | Intellia Therapeutics, Inc. |
| VRTX | Vertex Pharmaceuticals Incorporated |
| CRBU | Caribou Biosciences, Inc. |
| EDIT | Editas Medicine, Inc. |
| SANA | Sana Biotechnology, Inc. |
BEAM Ownership FAQ
Who Owns Beam Therapeutics?
Beam Therapeutics is owned by institutional shareholders (57.16%), insiders (1.44%), and public (41.40%). The largest institutional shareholder of Beam Therapeutics is ARK INVESTMENT MANAGEMENT LLC (10.61% of total shares) and the top mutual fund owner is Ark ETF Trust (1.02% of total shares).
Who are the major institutional shareholders of Beam Therapeutics?
Beam Therapeutics's major institutional shareholders are ARK INVESTMENT MANAGEMENT LLC, VANGUARD GROUP INC, BLACKROCK INC., FMR LLC, and FARALLON CAPITAL MANAGEMENT LLC. The top five shareholders own together 41.31% of the company's share outstanding.
How many Beam Therapeutics shareholders are there?
As of Mar 2024, there are 154 institutional shareholders of Beam Therapeutics.
What percentage of Beam Therapeutics is owned by ARK INVESTMENT MANAGEMENT LLC?
ARK INVESTMENT MANAGEMENT LLC owns 8.18M shares of Beam Therapeutics, representing 10.61% of the company's total shares outstanding, valued at $270.34B (as of Mar 2024).
What percentage of Beam Therapeutics is owned by VANGUARD GROUP INC?
As of Mar 2024, VANGUARD GROUP INC holds 7.58M shares of Beam Therapeutics (BEAM), compromising 9.82% of the company, valued at $250.4M.
What percentage of Beam Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Beam Therapeutics. The company owns 6.71M of the company's shares outstanding (worth $221.55M).